company background image
DNA

Donaco InternationalASX:DNA Stock Report

Market Cap

AU$42.0m

7D

-1.4%

1Y

9.7%

Updated

26 Sep, 2021

Data

Company Financials
DNA fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance2/6
Financial Health3/6
Dividends0/6

DNA Overview

Donaco International Limited engages in leisure and entertainment businesses in the Asia Pacific region.

Price History & Performance

Summary of all time highs, changes and price drops for Donaco International
Historical stock prices
Current Share PriceAU$0.034
52 Week HighAU$0.029
52 Week LowAU$0.092
Beta2.32
1 Month Change0%
3 Month Change-12.82%
1 Year Change9.68%
3 Year Change-80.57%
5 Year Change-92.84%
Change since IPO-92.09%

Recent News & Updates

Sep 07
Robust Earnings May Not Tell The Whole Story For Donaco International (ASX:DNA)

Robust Earnings May Not Tell The Whole Story For Donaco International (ASX:DNA)

Donaco International Limited's ( ASX:DNA ) healthy profit numbers didn't contain any surprises for investors. We...

May 26
Is Donaco International (ASX:DNA) A Risky Investment?

Is Donaco International (ASX:DNA) A Risky Investment?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Feb 18
How Much Did Donaco International's(ASX:DNA) Shareholders Earn From Share Price Movements Over The Last Five Years?

How Much Did Donaco International's(ASX:DNA) Shareholders Earn From Share Price Movements Over The Last Five Years?

It is a pleasure to report that the Donaco International Limited ( ASX:DNA ) is up 78% in the last quarter. But will...

Shareholder Returns

DNAAU HospitalityAU Market
7D-1.4%0.5%-0.9%
1Y9.7%47.2%24.4%

Return vs Industry: DNA underperformed the Australian Hospitality industry which returned 47.2% over the past year.

Return vs Market: DNA underperformed the Australian Market which returned 24.4% over the past year.

Price Volatility

Is DNA's price volatile compared to industry and market?
DNA volatility
DNA Beta2.32
Industry Beta1.23
Market Beta1

Stable Share Price: DNA is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 11% a week.

Volatility Over Time: DNA's weekly volatility (11%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1990n/aTechatut Sukcharoenkraisri Huyhttps://www.donacointernational.com

Donaco International Limited engages in leisure and entertainment businesses in the Asia Pacific region. It operates Star Vegas Resort & Club, a casino and hotel complex comprising approximately 150 gaming tables, 1,000 slot machines, and 385 hotel rooms in Poipet, Cambodia; and Aristo International Hotel, a boutique casino comprising 400 hotel rooms in northern Vietnam located on the border with Yunnan Province, China. The company was incorporated in 1990 and is based in Sydney, Australia.

Donaco International Fundamentals Summary

How do Donaco International's earnings and revenue compare to its market cap?
DNA fundamental statistics
Market CapAU$42.00m
Earnings (TTM)AU$25.18m
Revenue (TTM)AU$10.32m

1.7x

P/E Ratio

4.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
DNA income statement (TTM)
RevenueAU$10.32m
Cost of RevenueAU$7.20m
Gross ProfitAU$3.12m
Expenses-AU$22.06m
EarningsAU$25.18m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.02
Gross Margin30.19%
Net Profit Margin243.98%
Debt/Equity Ratio6.8%

How did DNA perform over the long term?

See historical performance and comparison

Valuation

Is Donaco International undervalued compared to its fair value and its price relative to the market?

1.67x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate DNA's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate DNA's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: DNA is good value based on its PE Ratio (1.7x) compared to the Australian Hospitality industry average (35.3x).

PE vs Market: DNA is good value based on its PE Ratio (1.7x) compared to the Australian market (19.1x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate DNA's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: DNA is good value based on its PB Ratio (0.3x) compared to the AU Hospitality industry average (3.7x).


Future Growth

How is Donaco International forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

29.4%

Forecasted Consumer Services industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Donaco International has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Donaco International performed over the past 5 years?

-25.2%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: DNA has a large one-off gain of A$42.5M impacting its June 30 2021 financial results.

Growing Profit Margin: DNA became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: DNA has become profitable over the past 5 years, growing earnings by -25.2% per year.

Accelerating Growth: DNA has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: DNA has become profitable in the last year, making it difficult to compare its past year earnings growth to the Hospitality industry (4.2%).


Return on Equity

High ROE: DNA's Return on Equity (15.3%) is considered low.


Financial Health

How is Donaco International's financial position?


Financial Position Analysis

Short Term Liabilities: DNA's short term assets (A$8.6M) do not cover its short term liabilities (A$28.7M).

Long Term Liabilities: DNA's short term assets (A$8.6M) exceed its long term liabilities (A$7.7M).


Debt to Equity History and Analysis

Debt Level: DNA's debt to equity ratio (6.8%) is considered satisfactory.

Reducing Debt: DNA's debt to equity ratio has reduced from 31.6% to 6.8% over the past 5 years.

Debt Coverage: DNA's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if DNA's interest payments on its debt are well covered by EBIT.


Balance Sheet


Dividend

What is Donaco International current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate DNA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate DNA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if DNA's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if DNA's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: DNA is not paying a notable dividend for the Australian market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of DNA's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.6yrs

Average management tenure


CEO

Techatut Sukcharoenkraisri Huy

1

Tenure

AU$81,607

Compensation

Mr. Lee Bug Huy, also known as Techatut Sukcharoenkraisri, serves as Chief Executive Officer and Executive Director at Donaco International Limited since September 03, 2020. He was Non-Executive Director a...


CEO Compensation Analysis

Compensation vs Market: Insufficient data to establish whether Techatut Sukcharoenkraisri's total compensation is reasonable compared to companies of similar size in the Australian market.

Compensation vs Earnings: Techatut Sukcharoenkraisri's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: DNA's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.


Board Members

Experienced Board: DNA's board of directors are not considered experienced ( 1 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Donaco International Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Donaco International Limited
  • Ticker: DNA
  • Exchange: ASX
  • Founded: 1990
  • Industry: Casinos and Gaming
  • Sector: Consumer Services
  • Market Cap: AU$42.003m
  • Shares outstanding: 1.24b
  • Website: https://www.donacointernational.com

Location

  • Donaco International Limited
  • 25 Martin Place
  • Level 43
  • Sydney
  • New South Wales
  • 2000
  • Australia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/09/26 08:05
End of Day Share Price2021/09/24 00:00
Earnings2021/06/30
Annual Earnings2021/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.